The global RNA sample preparation market size was estimated to be USD 2.51 billion in 2023 and is expected to reach at USD 5.0 billion by 2033 with a CAGR of 6.45% during the forecast period 2023-2033. Rising product launches, increasing technological advancements, growing biotechnology industry, rising drug development activities, surging demand for personalised medicine, increasing investments, rising funding in research & development activities, and growing adoption of cutting-edge technologies such as wearable devices & artificial intelligence are the key factors driving the growth of this market.
Rising product launches is anticipated to propel the market growth during the forecast period. For instance, in February 2020, Covaris, Inc., launched two new kits, truXTRAC Viral RNA Extraction kit using Puritan® Swabs and truXTRAC-PCR Direct Viral RNA Extraction kit for viral RNA extraction from nasal or throat swab sample.
By product, kits was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to rise in research & development activities in area of DNA & RNA sample preparation, increasing technological advancements, and growing product launches. For instance, in April 2021, Germany-based medical equipment company Altona Diagnostics has unveiled the AltoStar HIV RT-PCR kit 1.5, a diagnostic solution capable of accurately detecting and monitoring viral loads of HIV, Hepatitis B, and Hepatitis C. This kit is specifically designed for the extraction of both DNA and RNA and has been validated for use with various types of samples. Additionally, Reagents & consumables is predicted to grow at fastest CAGR during the forecast period owing to the rising innovations in product offerings and rising new product launches.
By application, diagnostic testing was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to increasing number of patients suffering from chronic diseases that require diagnostic testing and increasing launch of new diagnostic testing kits by market players. For instance, in October 2022, Twist Biosciences has introduced the Human sample ID kit, which allows for the monitoring of whole blood samples throughout the laboratory testing process. This kit, compatible with Twist's next-generation sequencing workflows, seamlessly integrates into the workflow and ensures sample identification from whole blood or purified genomic DNA, maintaining traceability throughout the laboratory workflow. Additionally, Clinical testing is predicted to grow at fastest CAGR during the forecast period owing to the rising elderly population, increasing in chronic diseases, growing technological advancements, and surge in product launches.
By end-user, diagnostic centres was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to surge in number of patients visiting to diagnostic centres and rising launch of technologically advanced diagnostic testing. For instance, in March 2022, U.S.-based diagnostic company Beckman Coulter Life Sciences has introduced CellMek SPS, a fully automated sample preparation system designed for clinical flow cytometers. With this system, samples can be processed without manual intervention, as it enables automated washing, staining, and lysing. The CellMek SPS offers on-demand processing capabilities for various sample types, assisting laboratories in expanding their capabilities. Additionally, Academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the surge in research and development activities for the development of technologically advanced extraction kits.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing research & development activities and growing initiatives by market players such as mergers & acquisitions. For instance, in April 2020, Bio-Rad Laboratories Inc., a prominent global provider of research and clinical diagnostic products in the life science field, has acquired Celsee Inc, a biotechnology company based in the United States. Celsee specializes in developing instruments and consumables for isolating, detecting, and analyzing individual cells. Their Genesis System is capable of scaling from hundreds of thousands to millions of cells, facilitating genomic and proteomic applications. Additionally, the system can be utilized for enriching or monitoring circulating tumor cells, aiding in the assessment of disease progression and response to therapy. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in launch of advanced products. For instance, in May 2023, Mylab discovery solutions, a biotechnology company headquartered in India, has introduced the PathoDetect HSV Type 1&2 Detection kit. This multiplex real-time PCR test enables the detection and differentiation of herpes simplex virus type I (HSV-1) and type 2 (HSV-2) in a single tube.
Rising product launches is anticipated to propel the market growth during the forecast period. For instance, in February 2020, Covaris, Inc., launched two new kits, truXTRAC Viral RNA Extraction kit using Puritan® Swabs and truXTRAC-PCR Direct Viral RNA Extraction kit for viral RNA extraction from nasal or throat swab sample.
By product, kits was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to rise in research & development activities in area of DNA & RNA sample preparation, increasing technological advancements, and growing product launches. For instance, in April 2021, Germany-based medical equipment company Altona Diagnostics has unveiled the AltoStar HIV RT-PCR kit 1.5, a diagnostic solution capable of accurately detecting and monitoring viral loads of HIV, Hepatitis B, and Hepatitis C. This kit is specifically designed for the extraction of both DNA and RNA and has been validated for use with various types of samples. Additionally, Reagents & consumables is predicted to grow at fastest CAGR during the forecast period owing to the rising innovations in product offerings and rising new product launches.
By application, diagnostic testing was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to increasing number of patients suffering from chronic diseases that require diagnostic testing and increasing launch of new diagnostic testing kits by market players. For instance, in October 2022, Twist Biosciences has introduced the Human sample ID kit, which allows for the monitoring of whole blood samples throughout the laboratory testing process. This kit, compatible with Twist's next-generation sequencing workflows, seamlessly integrates into the workflow and ensures sample identification from whole blood or purified genomic DNA, maintaining traceability throughout the laboratory workflow. Additionally, Clinical testing is predicted to grow at fastest CAGR during the forecast period owing to the rising elderly population, increasing in chronic diseases, growing technological advancements, and surge in product launches.
By end-user, diagnostic centres was the highest revenue-grossing segment in the global RNA sample preparation market in 2022 owing to surge in number of patients visiting to diagnostic centres and rising launch of technologically advanced diagnostic testing. For instance, in March 2022, U.S.-based diagnostic company Beckman Coulter Life Sciences has introduced CellMek SPS, a fully automated sample preparation system designed for clinical flow cytometers. With this system, samples can be processed without manual intervention, as it enables automated washing, staining, and lysing. The CellMek SPS offers on-demand processing capabilities for various sample types, assisting laboratories in expanding their capabilities. Additionally, Academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the surge in research and development activities for the development of technologically advanced extraction kits.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing research & development activities and growing initiatives by market players such as mergers & acquisitions. For instance, in April 2020, Bio-Rad Laboratories Inc., a prominent global provider of research and clinical diagnostic products in the life science field, has acquired Celsee Inc, a biotechnology company based in the United States. Celsee specializes in developing instruments and consumables for isolating, detecting, and analyzing individual cells. Their Genesis System is capable of scaling from hundreds of thousands to millions of cells, facilitating genomic and proteomic applications. Additionally, the system can be utilized for enriching or monitoring circulating tumor cells, aiding in the assessment of disease progression and response to therapy. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in launch of advanced products. For instance, in May 2023, Mylab discovery solutions, a biotechnology company headquartered in India, has introduced the PathoDetect HSV Type 1&2 Detection kit. This multiplex real-time PCR test enables the detection and differentiation of herpes simplex virus type I (HSV-1) and type 2 (HSV-2) in a single tube.
Segmentation: RNA Sample Preparation Market Report 2022-2033
RNA Sample Preparation Market Analysis & Forecast By Product 2022-2033 (Revenue USD Bn)
Kits
- RNA Sample Preparation
- DNA Sample Preparation
- Workstation
- Reagents & Consumables
RNA Sample Preparation Market Analysis & Forecast By Application 2022-2033 (Revenue USD Bn)
- Diagnostic Testing
- Clinical Testing
- Research Applications
RNA Sample Preparation Market Analysis & Forecast By End-user 2022-2033 (Revenue USD Bn)
- Hospitals
- Academic & Research Institutes
- Diagnostic Centres
- Contract Research Organizations
- Forensic Science Laboratories
RNA Sample Preparation Market Analysis & Forecast by Region 2022-2033 (Revenue USD Bn)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. RNA Sample Preparation Market: Product Estimates & Trend Analysis
8. RNA Sample Preparation Market: Application Estimates & Trend Analysis
9. RNA Sample Preparation Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America RNA Sample Preparation Market
12. Europe Global RNA Sample Preparation Market
13. Asia Pacific Global RNA Sample Preparation Market
14. Latin America Global RNA Sample Preparation Market
15. MEA Global RNA Sample Preparation Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Agilent Technologies Inc.
- Becton
- Dickinson and Company
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A
- F. Hoffman-La Roche
- Miroculus Inc.
- Illumina Inc.
- Perkin Elmer Inc.
- QIAGEN
- Sigma Aldrich Corp.
- Tecan Group AG
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | July 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 2.51 Billion |
| Forecasted Market Value ( USD | $ 5 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
